MD. Israel Gutierrez

Israel is an accomplished Global Executive with 25 years of experience building multi-
therapeutic area medical affairs, clinical development, and drug safety. He has been
working with multiple companies in many layers of executive management in the areas
of Drug development, Risk Management, Artificial Intelligence implementation and PV
Strategy. He is currently Vice President of Drug Safety and Pharmacovigilance at
Compugen Ltd. He has been the VP of safety and PV in multiple groups including
Geron Inc, Watosa Therapeutics, Vicapsys, Exelixis, Pharmion Corp, Neurosystec,
and Encore Pharma Inc.. He has provided leadership of multifunctional groups across
large companies including PRA Health Sciences, Pharmacyclics, Abbvie, Genentech,
Roche Ltd, Celgene, and Myriad Pharmaceuticals. He is a physician and surgeon from
Universidad Autonoma de Guadalajara, Science Fellow in Cardiology and
Endocrinology from University of Southern California (USC). He is a Fellow of the
Royal Society of Public Health in London, and a Fellow of the Royal Society of